ICD-10-CM Billable Code

G40.91

Epilepsy, unspecified, intractable

Clinical Classification Guidelines

Inclusion Terms

  • Intractable seizure disorder NOS

Medical Intelligence & Overview

Intractable epilepsy, also known as drug-resistant epilepsy, is a neurological condition characterized by recurrent seizures that do not respond adequately to medication. When seizures persist despite treatment efforts, they are classified as intractable or refractory. This condition can significantly impact daily life, requiring careful management and specialized care to reduce seizure frequency and improve quality of life.

Causes & Symptoms

Clinical Causes: Genetic factors that influence brain activity Structural brain abnormalities, such as scar tissue from injury or stroke Brain injuries resulting from trauma or infections Developmental disorders affecting brain function Certain neurological diseases and conditions Unknown causes in many cases, highlighting the complexity of epilepsy Inadequate response to anti-epileptic medications despite proper use and adherence

Key Symptoms: Recurrent seizures that may vary in presentation Seizures lasting from a few seconds to several minutes Loss of consciousness or awareness during seizures Sudden movements, convulsions, or muscle stiffness Altered sensations or perceptions preceding seizures Confusion or fatigue post-seizure Potential deterioration of daily functioning due to uncontrolled seizures Possible side effects from medications used to manage epilepsy

Diagnostic & Treatment

Diagnosis Path: Diagnosis of intractable epilepsy involves a comprehensive evaluation, including: - Detailed medical history review - Description and documentation of seizure activity - Neurological examinations - Electroencephalogram (EEG) recordings to detect abnormal brain activity - Brain imaging studies such as MRI or CT scans to identify structural issues - Additional tests as needed to rule out other conditions Clinicians assess the frequency, duration, and severity of seizures to determine if they are resistant to treatment, classifying the condition as intractable when seizure control remains elusive despite appropriate therapy.

Treatment Protocols: Management of intractable epilepsy typically involves a multidisciplinary approach, which may include: - Optimization of anti-epileptic drug regimens to improve seizure control - Considering surgical options, such as resective surgery or neurostimulation, in suitable candidates - Application of neurostimulation therapies like vagus nerve stimulation (VNS) or responsive neurostimulation (RNS) - Dietary therapies, such as the ketogenic diet, particularly in pediatric cases - Lifestyle modifications to minimize seizure triggers - Supportive care, including counseling and educational resources, to help cope with the condition - Regular follow-up with healthcare providers to monitor treatment efficacy and adjust plans accordingly It is crucial for individuals with intractable epilepsy to work closely with neurologists and epilepsy specialists for personalized treatment strategies that aim to reduce seizure frequency and improve their overall well-being.

Reimbursement claims with a date of service on or after October 1, 2015 require the use of ICD-10-CM codes.

Clinical Advice & FAQs

Billing Guidance

Is G40.91 a billable ICD-10 code?
Yes, G40.91 is a specific, billable code that can be used to indicate a diagnosis for reimbursement purposes.

Documentation

How do I report G40.91?
Clinical documentation must specify the nature of Epilepsy, unspecified, intractable and any associated comorbidities for accurate reporting.

Cite this Clinical Reference